Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 02:30 ET | Source: Cantoni Therapeutics

Cantoni Therapeutics secures financing to advance novel non-incretin obesity drug into IND enabling phase

Brabant Development Agency (BOM) and angel investor join lead investor Libertatis Ergo Holding (LEH) in providing funding, with additional financial support from Brabant Startup Fund (BSF)Cantoni...